알레르기성 비염에서 황련-감초 하태독법의 IL-4활성 조절을 통한 항염증효과
Anti-inflammatory effects of Hataedock with Coptidis Rhizoma and Glycyrrhiza Uralensis on Allergic Rhinitis through Regulating IL-4 Activation
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
The aim of this study is to evaluate the anti-inflammatory effect of Hataedock treatment using Coptidis Rhizome and Glycyrrhiza Uralensis (CG) mixed extract in allergic rhinitis induced NC/Nga mice. We divided NC/Nga mice into 3 groups as follows; allergic rhinitis-induced group after CG Hataedock treatment (CGT, n=10), no treatment group (Ctrl), allergic rhinitis elicited group (ARE). To induce allergic rhinitis, NC/Nga mice of 3 weeks age were sensitized on 7, 8 and 9week by Ovalbumin (OVA) antigen in intranasal space. Hataedock using CG extract was administered on week 3 in allergic rhinitis-induced group (CGT) after Hataedock treatment. To identify distribution of Interlukin (IL)-4, Cluster of differentiation 40 (CD40), high-affinity IgE receptor (FcɛRI), substance P, Matrix metallopeptidase 9 (MMP-9), Nuclear factor-κB (NF-κB) p65, Inducible nitric oxide synthase (iNOS) and Cycloxygenase-2 (COX-2), we used histological examination. CGT significantly inhibited IL-4 and CD40 response compared with ARE. The reduction of Th2 cytokine expression decreased inflammatory mediators such as FcɛRI, substance P, MMP-9, NF-κB p65, iNOS and COX-2. Such immunological improvement induced reduction of respiratory epithelial damage and mucin secretion in goblet cell. These results indicate that Hataedock treatment suppresses allergic rhinitis through modulating of Th2 responses and diminishing various inflammatory mediators in nasal mucosal tissue. It might have potential applications for prevention and treatment of allergic rhinitis.
Abstract
The aim of this study is to evaluate the anti-inflammatory effect of Hataedock treatment using Coptidis Rhizome and Glycyrrhiza Uralensis (CG) mixed extract in allergic rhinitis induced NC/Nga mice. We divided NC/Nga mice into 3 groups as follows; allergic rhinitis-induced group after CG Hataedock treatment (CGT, n=10), no treatment group (Ctrl), allergic rhinitis elicited group (ARE). To induce allergic rhinitis, NC/Nga mice of 3 weeks age were sensitized on 7, 8 and 9week by Ovalbumin (OVA) antigen in intranasal space. Hataedock using CG extract was administered on week 3 in allergic rhinitis-induced group (CGT) after Hataedock treatment. To identify distribution of Interlukin (IL)-4, Cluster of differentiation 40 (CD40), high-affinity IgE receptor (FcɛRI), substance P, Matrix metallopeptidase 9 (MMP-9), Nuclear factor-κB (NF-κB) p65, Inducible nitric oxide synthase (iNOS) and Cycloxygenase-2 (COX-2), we used histological examination. CGT significantly inhibited IL-4 and CD40 response compared with ARE. The reduction of Th2 cytokine expression decreased inflammatory mediators such as FcɛRI, substance P, MMP-9, NF-κB p65, iNOS and COX-2. Such immunological improvement induced reduction of respiratory epithelial damage and mucin secretion in goblet cell. These results indicate that Hataedock treatment suppresses allergic rhinitis through modulating of Th2 responses and diminishing various inflammatory mediators in nasal mucosal tissue. It might have potential applications for prevention and treatment of allergic rhinitis.
참고문헌 (39)
- Bousquet J, "Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)", Allergy, 63(Suppl 86), pp.8~160 (2008)
- Nathan RA, "The burden of allergic rhinitis", Allergy Asthma Proc, 28(1), pp.3~9 (2007)
- 이민정, "만성비염 환아의 수면의 질과 성장에 관한 임상적 연구", 대한한방소아과학회지, 22(2), pp.125~139 (2008), 대한한방소아과학회
- Marino-Sanchez F, "Multimorbidities of Pediatric Allergic Rhinitis", Curr Allergy Asthma Rep, 19(2), pp.13~ (2019)
- Seth D, "Intranasal Steroid Therapy for Allergic Rhinitis", Pediatr Ann, 48(1), pp.e43~e48 (2019)
- 허규영, "알레르기 면역요법", 천식 및 알레르기, 30(3), pp.153~183 (2010), 대한천식알레르기학회
- The Korean Academy of Asthma AaCI, "Asthma and allergic diseases", pp.625~635 (2012), Yeomungak
- Lou H, "Imbalance between Th1 and Th2 cells in cord blood is influenced by maternal allergic rhinitis and associated with atopic dermatitis during the first two years of life", Chinese journal of otorhinolaryngology head and neck surgery, 49(5), pp.390~394 (2014)
- Krasnow J, "Implantation and early pregnancy: Endometrial Th2 cytokine expression throughout the menstrual cycle and early pregnancy", 11(8), pp.1747~1754 (1996)
- Berger A., "Th1 and Th2 responses: what are they?", BMJ, 321(7258), pp.424~ (2000)
- Eifan AO, "Pathogenesis of rhinitis", Clin Exp Allergy, 46(9), pp.1139~1151 (2016)
- Mallol J, "The International Study of Asthma and Allergies in Childhood(ISAAC)Phase Three : a global synthesis", Allergologia et immunopathologia, 41(2), pp.73~85 (2013)
- Kang MY, "A study on fetal toxicosis removal therapy", J Pediatr Korean Med, 17(1), pp.29~51 (2003)
- Jung AR, "Douchi (fermented Glycine max Merr.) alleviates atopic dermatitis-like skin lesions in NC", Nga mice by regulation of PKC and IL-4, 2016, pp.16(1), 416~
- 최준용, "두시하태독법의 Th2 분화 조절을 통한 알레르기 비염 완화 효과", 대한한방내과학회지, 38(4), pp.468~478 (2017), 대한한방내과학회
- 차호열, "황련-감초 추출물을 이용한 하태독법이 NC", Nga 생쥐에서 유발된 아토피 유사 피부염에 미치는 항염증 효과, 2015, pp.36(4), 486~497[DOI]
- 안상현, "두시 하태독법이 시행된 비만 생쥐에서 Th2 분화조절을 통한 알러지성 비염 유발 감소 효과", 대한한방소아과학회지, 32(2), pp.1~10 (2018), 대한한방소아과학회[DOI]
- 송지훈, "두시를 이용한 하태독법의 NC", Nga 생쥐에서 DNFB로 유발된 피부손상 완화 효과, 2016, pp.30(2), 109~115[DOI]
- Cha HY, "Hataedock treatment has preventive therapeutic effects for atopic dermatitis through skin barrier protection in Dermatophagoides farinae-induced NC", Nga mice, 2017, pp.206, 327~336
- 김미연, "하태독법을 시행 받은 아동의 어머니를 대상으로 한 만족도 조사", 대한한방소아과학회지, 31(4), pp.39~48 (2017), 대한한방소아과학회
- Adkins B, "Newborn mice develop balanced Th1", Th2 primary effector responses in vivo but are biased to Th2 secondary responses, 1998, pp.160(9), 4217~4224
- Lee HM, "Expression of MMP-9 and TIMP-1 in the Nasal Mucosa of Allergic Rhinitis", Korean J Otolaryngol, 43, pp.604~609 (2000)
- Zhu R, "A study of costimulatory molecules in allergic allergic rhinitis patients", Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 22(17), pp.780~782 (2008)
- Saunderson SC, "Induction of exosome release in primary B cells stimulated via CD40 and the IL-4 receptor", J Immunol, 180(12), pp.8146~8152 (2008)
- Amin K, "The role of mast cells in allergic inflammation", Respir Med, 106(1), pp.9~14 (2012)
- Zhang RX, "The role of substance P, gene regulation and PM2.5 in the pathogenesis of allergic rhinitis", Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 53(10), pp.725~729 (2018)
- Sachiko Mori, "Expression and Roles of MMP-2, MMP-9, MMP-13, TIMP-1, and TIMP-2 in Allergic Nasal Mucosa", Allergy, Asthma & Immunology Research, 4(4), pp.231~239 (2012), 대한천식알레르기학회[DOI]
- Hanf G, "Substance P induced histamine release from nasal mucosa of subjects with and without allergic rhinitis", Inflamm Res, 49(10), pp.520~523 (2000)
- Barnes PJ, "NF-kappa B : a pivotal role in asthma and a new target for therapy", Trends Pharmacol Sci, 18(2), pp.46~50 (1997)
- Kim ST, "Expression of NF-K B and I-K B in Allergic Rhinitis", Korean J Otorhinolaryngol-Head Neck Surg, 43(11), pp.1191~1195 (2000)
- Mendes KL, "Nuclear sirtuins and inflammatory signaling pathways", Cytokine Growth Factor Rev, 38, pp.98~105 (2017)
- Na HK, "Role of Cyclooxygenase-2 and Its Products in the Regulation of Cell Growth", J of Korean Assoc, 8(4), pp.251~260 (2003)
- Li S, "Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network", IET Syst Biol, 1(1), pp.51~60 (2007)
- Heo J, "Donguibogam", pp.2976~ (2019), Yegang publish
- Li Z, "Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus", Evid Based Complementary Altern Med, 2014, pp.289264~ (2014)
- Lin WC, "Berberine down-regulates the Th1", Th2 cytokine gene expression ratio in mouse primary splenocytes in the absence or presence of lipopolysaccharide in a preventive manner, 2011, pp.11(12), 1984~1990
- Ding JW, "Glycyrrhizin, a High-Mobility Group Box 1 Inhibitor, Improves Lipid Metabolism and Suppresses Vascular Inflammation in Apolipoprotein E Knockout Mice", J Vasc Res, 55(6), pp.365~377 (2018)
- Bordbar N, "The effect of glycyrrhizin on maturation and T cell stimulating activity of dendritic cells", Cell Immunol, 280(1), pp.44~49 (2012)
- Yu JY, "Anti-Inflammatory activities of licorice extract and its active compounds, glycyrrhizic acid, liquiritin and liquiritigenin, in BV2 cells and mice liver", Molecules, 20(7), pp.13041~13054 (2015)
